B O O K - American College of Rheumatology

4:30 PM
2198. Association between Vascular Physical Examination
Findings and Angiographically-Detected Arterial Lesions in
Subjects with Large Vessel Vasculitis.
Peter C. Grayson 4 , Gunnar Tomasson 3 , David Cuthbertson 11 ,
Simon Carette 9 , Gary S. Hoffman 6 , Nader A. Khalidi 10 , Carol A.
Langford 5 , Carol McAlear 4 , Paul A. Monach 1 , Philip Seo 7 , Kenneth
J. Warrington 8 , Steven R. Ytterberg 8 and Peter A. Merkel 2 ,
1
Boston University, Boston, MA, 2 Boston University School of
Medicine, West Newton, MA, 3 Boston University School of
Medicine, Boston, MA, 4 Boston University School of Medicine,
5
Cleveland Clinic Foundation, Cleveland, OH, 6 Cleveland Clinic
Foundation, Pepper Pike, OH, 7 Johns Hopkins Bayview Medical
Center, Baltimore, MD, 8 Mayo Clinic, Rochester, MN, 9 Toronto
Western Hospital, Toronto, ON, Canada, 10 University of Hamilton,
Hamilton, ON, Canada, 11 University of South Florida
4:45 PM
2199. Sex, Age, and Birth Cohort Effects on Incidence of Giant
Cell Arteritis.
Maureen Dubreuil 1 , Hyon K. Choi 2 , Yuqing Zhang 2 and Yanyan
Zhu 2 , 1 Boston Medical Center, Boston, MA, 2 Boston University
School of Medicine, Boston, MA
5:00 PM
2200. Identification of JAK1 as a Candidate Inflammatory
Signalling Pathway by Genome-Wide Expression Profiling in
Monocytes from Patients with Behcet’s Disease.
Haner Direskeneli 3 , Joseph J. Boyle 1 , Filiz T. Ozdemir 3 , Vuslat
Yilmaz 2 , Emel Eksioglu-Demiralp 3 , Dorian Haskard 1 and Guher
Saruhan-Direskeneli 2 , 1 Cardiovascular Sciences Centre, Imperial
College, London, United Kingdom, 2 Istanbul University, Istanbul
Faculty of Medicine, Istanbul, Turkey, 3 Marmara University,
School of Medicine, Istanbul, Turkey
5:15 PM
2201. A Randomized, Controlled, Multicenter Phase III Study
of the Efficacy and Safety of Rituximab (RTX) Monotherapy
Versus the Best Available Treatment in Patients with Mixed
Cryoglobulinemia Syndrome.
Salvatore De Vita 15 , Luca Quartuccio 15 , Miriam Isola 8 , Paola
Masolini 16 , Stefania Sacco 15 , Ginevra De Marchi 15 , Cesare
Mazzaro 6 , Patrizia Scaini 13 , Marco Lenzi 4 , Mauro Campanini 1 ,
Salvatore Scarpato 21 , Antonio Tavoni 20 , Maurizio Pietrogrande 9 ,
Clodoveo Ferri 19 , Maria Teresa Mascia 18 , Dario Roccatello 3 , Anna
Linda Zignego 2 , Paolo Pioltelli 11 , Armando Gabrielli 12 , Davide
Filippini 14 , Oreste Perrella 5 , Sergio Migliaresi 17 , Massimo Galli 7 ,
Giuseppe Monti 10 and Stefano Bombardieri 20 , 1 A.O. Maggiore-
Medicina II, Novara, Italy, 2 Center for Systemic Manifestations
of Hepatitis Viruses (MaSVE), Department of Internal Medicine,
University of Florence, Florence, Italy, 3 Centro di Ricerche
di Immunopatologia e Documentazione su Malattie Rare,
Struttura Complessa a Direzione Universitaria di Immunologia
Clinica, Ospedale S.G. Bosco, Torino, Italy, 4 Department of
Clinical Medicine, University of Bologna, S. Orsola-Malpighi
Hospital, Bologna, Italy, 5 Department of Infectious Diseases and
Immunology, Cotugno Hospital, Naples, Italy, 6 Department of
Internal Medicine, Pordenone General Hospital, Pordenone,
Italy, 7 Dipartimento di Scienze Cliniche Luigi Sacco, Sezione di
Malattie Infettive e Immunopatologia, Università degli Studi,
Ospedale Luigi Sacco, Milano, Italy, 8 Institute of Statistics,
University of Udine, Udine, Italy, Italy, 9 Internal Medicine Unit,
Policlinico San Marco, Bergamo, Italy, Italy, 10 Internal Medicine
Unit, Saronno Hospital, Azienda Ospedaliera di Busto Arsizio,
Saronno, VA, Italy, Italy, 11 Internal Medicine, Donizetti Hospital,
Monza, Italy, Italy, 12 Internal Medicine, Università Politecnica
delle Marche, Ancona, Italy, Italy, 13 Nephrology Unit, Spedali
Riuniti, Brescia, Italy, Italy, 14 Rheumatology Clinic, A.O. Niguarda
Ca’ Granda Hospital, Milan, Italy, 15 Rheumatology Clinic, Azienda
Ospedaliero-Universitaria “S. Maria della Misericordia”, Udine,
Italy, 16 Rheumatology Clinic, Azienda Ospedaliero-Universitaria
“S. Maria della Misericordia”, Udine, Italy, 17 Rheumatology
Clinic, University of Naples, Italy, Italy, 18 Rheumatology Unit,
Department of Internal Medicine, University of Modena e Reggio
Emilia, Italy, Italy, 19 Rheumatology Unit, Department of Internal
Medicine, University of Modena, Italy, Italy, 20 Rheumatology
Unit, Department of Internal Medicine, University of Pisa, Pisa,
Italy, Italy, 21 Rheumatology Unit, M. Scarlato Hospital, Scafati,
Salerno, Italy, Italy
5:30 PM
2202. A New Polymorphism of the Fibroblast Growth Factor
(FGF)23 Gene: A Promising Predictor of Coronary Damage in
Kawasaki Disease (KD).
Fernanda Falcini 1 , Laura Masi 3 , Francesco Franceschelli 3 , Gigliola
Leoncini 3 , Serena Capannini 1 , Francesco La Torre 4 , Giuseppina
Calcagno 4 , Marco Matucci Cerinic 2 and Maria Luisa Brandi 3 ,
1
Department of BioMedicine, Section of Rheumatology,
Transition Clinic, University of Florence, Florence, Italy,
2
Department of BioMedicine, Section of Rheumatology,
Transition Clinic, University of Florence, Florence, Italy,
3
Department of Internal Medicine, Metabolic Bone Diseases
Unit, University of Florence, Italy, 4 Department of Paediatrics,
Rheumatology Unit, University of Messina
5:45 PM
2203. Mepolizumab, a Humanized Anti-IL-5 Antibody, Has
Steroid-Sparing Potential in Churg-Strauss Syndrome.
Frank Moosig 1 , Kristina Butherus 1 , Bernhard Hellmich 2 and
Wolfgang L. Gross 1 , 1 University Hospital Schleswig Holstein
& Klinikum Bad Bramstedt, 2 University of Tübingen &
Kreiskrankenhaus Plochingen
ACR Meet the Professor Sessions
4:30 - 6:00 PM
Admission to each Meet the Professor session requires a
separate registration and ticket. To verify which session you
registered for, check to make sure the registration code on your
ticket matches the code listed below in parentheses.
B207
Dermatological Manifestations of Rheumatic Diseases
(081) f
Speaker: Nicole Fett, MD; Perelman Center for Advanced
Medicine; Philadelphia, PA
Upon completion of this session, participants should be able to:
• cite the diagnostic criteria for skin diseases with
rheumatologic implications
• construct a differential diagnosis for these conditions
• design a strategy for management of skin disease seen in
patients with rheumatologic diseases
wednesday
2010 Program Book 129